Page 2900 - Cote clinical veterinary advisor dogs and cats 4th

Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables. 1547

Neoplasia (Continued) Nerve blocks, 1129–1130 NHSP. See Nutritional secondary hyperparathyroidism
anal sac, 53–54, 1399a Nerve conduction velocity, hypothermia effects on, Niacin, for hyperlipidemia, 498
1097.e1
Niacinamide
biliary tract, 446–448
VetBooks.ir bladder, 991–992 Nerve root signature, 893.e2–893.e3, 1278 administration and dosage of, 1496
Nerve sheath tumor, 692–693. See also
bone. See specific tumors
for episcleritis/scleritis, 305
bronchiolar, 134–135, 135f
for histiocytic diseases, 475
Hemangiopericytoma
tetracycline and, 771
cachexia and. See Cachexia, cancer-associated
oral, 714
cardiac, 407–408 injection sites and, 550 Niacinamide-tetracycline. See Tetracycline-niacinamide
cutaneous, 230–231, 230f, 230.e1f, 628–629, 1211 of spinal cord, 932 Nicorette, 693.e3
esophagus, 309.e5–309.e6 Nervosa anorexia, 831 Nicotiana spp.. See Tobacco
eyelid, 318–319, 319f Nervous system disorders. See Neurologic disorders Nicotinamide. See Niacinamide
fever of unknown origin and, 1223–1225 Neupogen. See Filgrastim Nicotine gum, 693.e3
gastric, 379–380 Neural larval migrans, Baylisascaris infection and, Nicotine skin patches, 693.e3
heart base tumor, 407–408 114.e2–114.e3 Nicotine toxicosis, 693.e3–693.e4
hepatic Neuroblastoma, peripheral, 692 Nicotinic insecticides, 693.e3
malignant, 446–448, 448.e1f Neurocardiogenic syncope, 953–955 Nicotrol, 693.e3
tumor types in, 1230 Neurofibroma, 692 Nictitating membrane. See Third eyelid
hypercalcemia and, 606 Neurofibrosarcoma, 692, 927. See also Niemann-Pick disease, 945.e2–945.e3
hypertrophic osteopathy and, 508 Hemangiopericytoma Nifedipine, 140–141
intraocular, 559–561, 560f injection site and, 550 Nifurtimox, for Chagas’ disease, 152
laryngeal, 573–574, 1250.e1 Neurogenic pulmonary edema, 836 Nilstat. See Nystatin
mammary gland Neurologic disorders Nim, 463t–464t
in cats, 621–623 anesthetic-related complications and, 65 Nimbi, 463t–464t
in dogs, 623–625 canine distemper and, 271 Nipride. See Nitroprusside
mediastinal. See Mediastinal masses collapse and, 193 Niridazole, for Dracunculus insignis infection, 275.e2
metastatic, and pulmonary nodules, 841 multiple organ dysfunction syndrome and, 666 Nit(s) (lice), 768f
nasal. See Nasal neoplasia priapism and, 821.e2 Nitazoxanide, for cryptosporidiosis, 226
nerve root signature and, 893.e2 seizures and, 903–904 Nitenpyram
nerve sheath. See Nerve sheath tumor urination disorders and, 89–91, 871 administration and dosage of, 1496
ocular, 559–561 voice change and, 1039–1040 for myiasis, 675
oral. See Oral tumors Neurologic examination Nitric oxide, in sepsis/septic shock, 907
orbital, 716–718 in coma, 197 Nitrofurantoin, 1496
pancreatic, 738–739 in degenerative myelopathy, 242 Nitroglycerin, 1496
pododermatitis and, 799 in intervertebral disc disease, 556 Nitropress. See Nitroprusside
prostatic, 828–830, 829.e1f procedure for, 1136–1137 Nitroprusside
pulmonary, 134–135, 135f visual pathways, 124, 124f for acute heart failure, 409
pulmonary nodules and, 840–842 Neurologic signs, 1259 administration and dosage of, 1496
renal, 876–878 Neurologic syncope, 954–955 for hypertension, 784
renomegaly and, 879.e4 Neuromuscular disorders Nizoral. See Ketoconazole
round cell tumors, 893–894, 894.e1f–894.e2f causes of, 1260 NMDA antagonists. See N-Methyl-D-aspartate (NMDA)
salivary gland, 894–897 collapse and, 193 antagonists
spinal cord, 932–933 tetraplegia/tetraparesis and, 967 Nocardia spp., 20, 398
subcutaneous, 628–629 Neuromyopathy, ischemic thromboembolic, 757 Nocardiosis, 20–21, 275.e3f
testicular, 962–963, 963f, 963.e1f–963.e2f Neuronal glycoproteinosis, 945.e2–945.e3 Nodular dermatofibrosis, 754, 756.e2–756.e3
third eyelid, 560f, 970–972 Neurontin. See Gabapentin Nodular dermatosis, 1437.e2a–1437.e3a
thyroid, 975–976 Neuropathy Nodular fasciitis, 304
tonsillar, 979 autonomic. See Dysautonomia Nodular granulomatous episcleritis/episclerokeratitis
tracheal, 1288 peripheral. See Peripheral neuropathy (NGE), 304
urinary bladder, 991–992 Neurotoxicity, blue-green algae and, 125.e2 Nodular hyperplasia, hepatic, 449–450
uterine, 1022–1023 Neutering. See Castration; Ovariohysterectomy Nodular regeneration, hepatic, 449–450
Neoral. See Cyclosporine Neutropenia, 1260.e1, 1368–1369 Nodular skin disorders, 694–695, 695f
Neorickettsia helminthoeca, 897–898, 1172.e2t–1172.e3t cobalamin deficiency and, 183 Noise phobia, 787
Neorickettsia ristcii, 1172.e2t–1172.e4t ehrlichiosis and, 286 Nolvasan. See Chlorhexidine
Neosar. See Cyclophosphamide immune-mediated, 693.e2–693.e3 Non-Hodgkin’s lymphoma, 607
Neospora caninum, 984–986, 1368 Neutrophil(s), 1368–1369. See also Neutropenia Non-necrotizing deep scleritis, 304
myocarditis and, 675 dysfunction of, 1260 Non-necrotizing superficial scleritis, 304
Neosporosis, 984–986 left shift in, 1357 Nonaccidental injury. See Abuse
Neostigmine Neutrophil function tests. See Leukocyte function tests Nonadherent dressings, 910
administration and dosage of, 1496 Neutrophilia, 1368–1369 Nonblanching dermal erythema, 1031.e5
for myasthenia gravis, 669 Neutrophilic cholangitis, 455 Noncardiogenic pulmonary edema, 28, 836–838. See also
Nephritis New methylene blue. See Methylene blue Acute respiratory distress syndrome (ARDS)
hereditary, and nephrotic syndrome, 691 Newfoundland calcium channel blocker toxicosis and, 141
interstitial, chronic. See Chronic kidney disease (CKD) cranial cruciate ligament injury in, 219 electrocution and, 292–293
Nephroblastoma dilated cardiomyopathy in, 263, 960 stridor/stertor and, 945
description of, 877 ectopic ureter in, 282 Nonchromaffin paraganglioma, 407
spinal cord, 932 ectropion in, 296 Noncompensatory pause, 97
Nephrogenic diabetes insipidus, 250–251, 1212 elbow dysplasia in, 288 Nonfebrile hyperthermia, 1238
Nephrogenic systemic fibrosis, 1133 familial nephropathy in, 169 Noninflammatory myopathies, 676.e2–676.e3
Nephrolithiasis, 689–690. See also Urolithiasis hip dysplasia in, 469 Nonpathologic heart murmurs, 413
Nephromegaly. See Renomegaly immune-mediated polymyositis in, 807.e2 Nonregenerative anemia, 63–64
Nephropathy megaesophagus in, 642 cobalamin deficiency and, 183
familial, 169 mitral valve dysplasia in, 657 laboratory testing for, 1306–1307
progressive juvenile. See Renal dysplasia osteochondrosis in, 723 Nonresponsive anemia. See Anemia, nonregenerative
protein-losing, 1444a patellar luxation in, 763 Nonsteroidal antiinflammatory drugs (NSAIDs). See also
Nephrosclerosis. See Chronic kidney disease (CKD) polymyositis in, 807.e2 specific drugs
Nephrotic syndrome, 691–692 primary ciliary dyskinesia in, 174.e2 for acute moist dermatitis, 26
Nephrotoxicity regurgitation in, 873 for aseptic necrosis of femoral head, 81
agents inducing, 1256 subaortic stenosis in, 948 for bite-related pain, 120.e3
chemotherapy and, 153–154 third eyelid disorders in, 970 corticosteroids and, for gastric ulcer, 382
Nephrotoxins, 23 urinary incontinence in, 538 for elbow dysplasia, 289
Nephroureterectomy, for ectopic ureter, 283 urolithiasis in, 1014.e2 fetal adverse effects and, 818
Neptazane. See Methazolamide Newtol, 1050 gastric ulcers and, 381
Nerium oleander toxicosis, 706–707, 707.e1f Nexium. See Esomeprazole glucocorticoids and, for gastric ulcer, 382
Nerve(s). See Peripheral nerve(s) NGE. See Nodular granulomatous episcleritis/ for granulocytic anaplasmosis, 394
Nerve biopsy, 1134.e1 episclerokeratitis (NGE) for hip dysplasia, 470
www.ExpertConsult.com